TRAPHAGEN INVESTMENT ADVISORS LLC

Position in BMY — Bristol Myers Squibb Co

CIK 2023380 ORADELL, NJ

Position in BMY

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$201,785

-$9,944 QoQ

Shares Held

3,502

+0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#2,158

of 2,514 holders

Holding Since

Mar 2020

17 quarters on record

Healthcare · as of Jun 30, 2026

TRAPHAGEN INVESTMENT ADVISORS LLC holds $8,468,712 across 7 Drug Manufacturers - General names. BMY ranks #7 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	9,821	$2,494,239
2	ABBV	AbbVie Inc.	9,472	$2,383,534
3	LLY	ELI LILLY & Co	1,286	$1,542,467
4	MRK	Merck & Co., Inc.	6,280	$806,980
5	PFE	Pfizer Inc	22,620	$544,689
6	AMGN	Amgen Inc	1,367	$495,018
7	BMY	Bristol Myers Squibb Co This page	3,502	$201,785

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$201,785	3,502	+0.3%	Shares	Sole	2026-07-16
2026-03-31	$211,729	3,491	+0.3%	Shares	Sole	2026-04-22
2023-09-30	$201,979	3,480	+7.1%	Shares	Sole	2024-06-17
2023-06-30	$207,837	3,250	+0.4%	Shares	Sole	2024-06-17
2023-03-31	$224,356	3,237	+0.4%	Shares	Sole	2024-06-17
2022-12-31	$232,038	3,225	+4.0%	Shares	Sole	2024-06-17
2022-09-30	$220,521	3,102	+0.3%	Shares	Sole	2024-06-17
2022-06-30	$238,084	3,092	+1.8%	Shares	Sole	2024-06-17
2022-03-31	$221,719	3,036	+144.8%	Shares	Sole	2024-06-17
2021-12-31	$77,314	1,240	0.0%	Shares	Sole	2024-06-17
2021-09-30	$73,370	1,240	0.0%	Shares	Sole	2024-06-17
2021-06-30	$82,856	1,240	-68.3%	Shares	Sole	2024-06-17
2021-03-31	$247,027	3,913	+2.3%	Shares	Sole	2024-06-17
2020-12-31	$237,264	3,825	-2.2%	Shares	Sole	2024-06-17
2020-09-30	$235,854	3,912	-3.4%	Shares	Sole	2024-06-17
2020-06-30	$238,140	4,050	-1.1%	Shares	Sole	2024-06-17
2020-03-31	$228,366	4,097	—	Shares	Sole	2024-06-17
No filing history on record for this holder in this stock.